Home > Compound List > Product Information
Mefloquine_Molecular_structure_CAS_53230-10-7)
Click picture or here to close

Mefloquine

Catalog No. DB00358 Name DrugBank
CAS Number 53230-10-7 Website http://www.ualberta.ca/
M. F. C17H16F6N2O Telephone (780) 492-3111
M. W. 378.3121592 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 242

SYNONYMS

IUPAC name
[2,8-bis(trifluoromethyl)quinolin-4-yl](piperidin-2-yl)methanol
IUPAC Traditional name
mefloquin
Brand Name
Lariam
Synonyms
Mefloquinone
Mefloquine HCL

DATABASE IDS

CAS Number 53230-10-7
PubChem CID 4046
PubChem SID 46505610

PROPERTIES

Hydrophobicity(logP) 3.9
Solubility 5000 mg/L (HCl salt)

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A phospholipid-interacting antimalarial drug (antimalarials). It is very effective against plasmodium falciparum with very few side effects. [PubChem]
Indication For the treatment of mild to moderate acute malaria caused by Mefloquineuine-susceptible strains of Plasmodium falciparum (both chloroquine-susceptible and resistant strains) or by Plasmodium vivax. Also for the prophylaxis of Plasmodium falciparum and Plasmodium vivax malaria infections, including prophylaxis of chloroquine-resistant strains of Plasmodium falciparum.
Pharmacology Mefloquine is an antimalarial agent which acts as a blood schizonticide. Mefloquine is active against the erythrocytic stages of Plasmodium species. However, the drug has no effect against the exoerythrocytic (hepatic) stages of the parasite. Mefloquine is effective against malaria parasites resistant to chloroquine. Mefloquine is a chiral molecule. According to some research, the (+) enantiomer is more effective in treating malaria, and the (-) enantiomer specifically binds to adenosine receptors in the central nervous system, which may explain some of its psychotropic effects.
Toxicity Oral, rat: LD50 = 880 mg/kg. Symptoms of overdose include nausea, vomiting, and weight loss.
Affected Organisms
Plasmodium
Biotransformation Hepatic. Two metabolites have been identified in humans. The main metabolite, 2,8-bis-trifluoromethyl-4-quinoline carboxylic acid, is inactive against Plasmodium falciparum. The second metabolite, an alcohol, is present in minute quantities.
Absorption Well absorbed from the gastrointestinal tract. The presence of food significantly enhances the rate and extent of absorption.
Half Life 2 to 4 weeks
Protein Binding 98%
Elimination There is evidence that mefloquine is excreted mainly in the bile and feces. Urinary excretion of unchanged mefloquine and its main metabolite under steady-state condition accounted for about 9% and 4% of the dose, respectively.
Distribution * 20 L/kg [healthy adults]
Clearance * 30 mL/min
External Links
Wikipedia
RxList
Drugs.com

REFERENCES